Body iron is a contributor to oxidative damage of DNA

References

• Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990; 186: 1–85
   PubMed Web of Science ®Google Scholar
• Ryan TP, Aust SD. The role of iron in oxygen-mediated toxicities. Crit Rev Toxicol 1992; 22: 119–141
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239–247
   PubMed Web of Science ®Google Scholar
• Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 1995; 18: 321–336
   PubMed Web of Science ®Google Scholar
• Shigenaga MK, Gimeno CJ, Ames BN. Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U.S.A. 1989; 86: 9697–9701
   PubMed Web of Science ®Google Scholar
• Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen HE. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 1992; 13: 2241–2247
   PubMed Web of Science ®Google Scholar
• Poulsen HE, Loft S, Prieme H, Vistisen K, Lykkesfeldt J, Nyyssönen K, Salonen JT. Oxidative DNA damage in vivo: Relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radic Res 1998; 29: 565–571
   PubMed Web of Science ®Google Scholar
• Loft S, Astrup A, Buemann B, Poulsen HE. Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J 1994; 8: 534–537
   PubMed Web of Science ®Google Scholar
• Poulsen HE, Loft S, Vistisen K. Extreme exercise and oxidative DNA modification. J Sports Sci 1996; 14: 343–346
   PubMed Web of Science ®Google Scholar
• Nakano M, Kawanishi Y, Kamohara S, Uchida Y, Shiota M, Inatomi Y, Komori T, Miyazawa K, Gondo K, Yamasawa I. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: A study on 2507 healthy people. Free Radic Biol Med 2003; 35: 826–832
   PubMed Web of Science ®Google Scholar
• Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 1974; 290: 1213–1216
   PubMed Web of Science ®Google Scholar
• Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: A quantitative measure of tissue iron deficiency. Blood 1990; 75: 1870–1876
   PubMed Web of Science ®Google Scholar
• Cook JD, Skikne B, Baynes R. The use of the serum ferritin receptor for the assessment of iron status. Iron nutrition in health and disease, L Hallberg, N-G Asp. JL London Press, London 1996; 49–58
   Google Scholar
• Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and it's ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997; 89: 1052–1057
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssönen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, Tuomainen T-P, Valkonen V-P, Ristonmaa U, Poulsen HE. Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: A randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000; 248: 377–386
   PubMed Web of Science ®Google Scholar
• Sullivan JL. Is stored iron safe?. J Lab Clin Med 2004; 144: 280–284
   PubMed Web of Science ®Google Scholar
• Barollo M, D'Inca R, Scarpa M, Medici V, Cardin R, Fries W, Angriman I, Sturniolo GC. Effects of iron deprivation or chelation on DNA damage in experimental colitis. Int J Colorectal Dis 2004; 19: 461–466
   PubMedGoogle Scholar
• Barollo M, D'Inca R, Scarpa M, Medici V, Cardin R, Bortolami M, Ruffolo C, Angriman I, Sturniolo GC. Effects of iron manipulation on trace elements level in a model of colitis in rats. World J Gastroenterol 2005; 11: 4396–4399
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Nakae D, Mizumoto Y, Horiguchi K, Tamura K, Denda A, Tsujii T, Konishi Y. Inhibitory effect of dietary iron deficiency on inductions of putative preneoplastic lesions as well as 8-hydroxydeoxyguanosine in DNA and lipid peroxidation in the livers of rats caused by exposure to a choline-deficient l-amino acid defined diet. Carcinogenesis 1002; 13: 1227–1233
   Google Scholar
• Kato J, Kobune M, Nakamura T, Kuroiwa G, Takada K, Takimoto R, Sato Y, Fujikawa K, Takahashi M, Takayama T, Ikeda T, Niitsu Y. Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet. Cancer Res 2001; 61: 8697–8702
   PubMed Web of Science ®Google Scholar
• Holmberg I, Stal P, Hamberg M. Quantitative determination of 8-hydroxy-2′-deoxyguanosine in human urine by isotope dilution mass spectrometry: Normal levels in hemochromatosis. Free Radic Biol Med 1999; 26: 129–135
   PubMed Web of Science ®Google Scholar
• Kom GD, Schwedhelm E, Nielsen P, Böger RH. Increased urinary excretion of 8-iso-prostaglandin F2α in patients with HFE-related hemochromatosi: A case-control study. Free Radic Biol Med 2006; 40: 1194–1200
   PubMedGoogle Scholar
• Kruszewski M. Labile iron pool: The main determinant of cellular response to oxidative stress. Mutat Res 2003; 531: 81–92
   PubMed Web of Science ®Google Scholar
• Gackowski D, Kruszewski M, Bartlomiejczyk T, Jawien A, Ciecierski M, Olinski R. The level of 8-oxo-7,8-dihydro-2′-deoxyguanosine is positively correlated with the size of the labile iron pool in human lymphocytes. J Biol Inorg Chem 2002; 7: 548–550
   PubMedGoogle Scholar
• Kakhlon O, Cabantchik ZI. The labile iron pool: Characterization, measurement, and participation in cellular processes. Free Radic Biol Med 2002; 33: 1037–1046
   PubMed Web of Science ®Google Scholar